Gabriele M. Cerrone
Executive Chairman at OKYO Pharma Limited
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 1 year
- Director since
- 2026
1 year of board service in total across 2 boards, counting each seat separately. Longest: OKYO Pharma Limited, 6 months.
OKYO Pharma Limited
Director · Executive Chairman
Tiziana Life Sciences Ltd.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | Tiziana Life Sciences Ltd. | Grant or award | +42,357 | $0.99 | $41,933 |
| Jul 21, 2026 | OKYO Pharma Limited | Grant or award | +22,500 | $1.45 | $32,625 |
| Jul 20, 2026 | OKYO Pharma Limited | Grant or award | +25,000 | $1.40 | $35,000 |
| Jun 12, 2026 | Tiziana Life Sciences Ltd. | Grant or award | +15,000 | $1.11 | $16,650 |
| Jun 8, 2026 | OKYO Pharma Limited | Grant or award | +300,000 | $1.72 | $516,000 |
| Oct 27, 2023 | OKYO Pharma Limited | Other | +70,071 | $1.50 | $105,107 |
| Oct 23, 2023 | OKYO Pharma Limited | Other | +499,468 | $1.50 | $749,202 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.